Norabuena, Gisela1
1 Service of Head, Neck and Maxillofacial Surgery, Hospital Nacional Arzobispo Loayza, Lima, Perú
Background: Thyroid cancer is the most common endocrine cancer is increasing worldwide. This research was conducted in Arzobispo Loayza National Hospital in Lima.
Objective: To identify epidemiological, clinical and surgical characteristics of thyroid cancer in the Arzobispo Loayza National Hospital in 2012 and 2013.
Methods: a descriptive study, no experimental cross-section, of a total of 124 patients with thyroid cancer the sample was 44.
Results: The prevalence of thyroid cancer in the surgery department of head and neck Arzobispo Loayza National Hospital is 21,29 cancers/ 100 patients and 21,32 cancers /100 patients in 2012 and 2013 respectively. The most common age group are over 60 (18.25%). Dominates the female gender (88.6%) with a female male ratio of 7.8: 1. Total thyroidectomy (75%) was performed and 34.1% presented a history of goiter. The biopsy with fine needle aspiration (FNA), performed preoperatively patients presented malignant cytology in 52.3%. The most common pathological outcome papillary carcinoma was 90.9%, 4.5% follicular carcinoma, medullary carcinoma and anaplastic carcinoma with 2.3% each.
Conclusion: The FNA as pathological findings in thyroid cancer, 45.5% had papillary carcinoma. With regard to the stage of diagnosis, stage I was (59.1%).
References:
- Álvarez, C. Thyroid cancer follow-up of cases in an Endocrinology Service. National University of La Plata. Argentina. 2007.
- Ignacio A., Ignacio H., Aguilar C., Cardona. J. Descriptive study of twelve years of thyroid cancer, Manizales, Colombia. Rev Colomb Cir. 2010; 25: 276-89.
- Ore J, Otárola M. Malignant thyroid pathology. Hospital Sabogal, Callao. Annals of the Faculty of Medicine. 2004; 65 (1): 36-41
- Zárate, X. et al. Report of a cohort of 197 patients with papillary thyroid cancer, operated at the National Institute of Medical Sciences “Salvador Zubirán” Nutrition. Mexico. Surgeon General Vol. 32 No. 4 – 2010.